Using the GuruFocus Aggregated Portfolio Screener you can filter results to see what companies maintain the highest amount of guru ownership. By using this screener, we filtered down to see which technology companies are held by the most gurus. As of the second quarter, the following five tech stocks are held by the largest number of gurus.
As of the close of the second quarter there were 55 guru owners of Microsoft. During the past quarter there were 20 gurus buying shares of MSFT and there were 34 gurus making sells of their stake in the company. These gurus maintain a combined weighting of 137.09%.
The top three guru shareholders of Microsoft:
1. Dodge & Cox: 77,260,349 shares, representing 0.93% of the company’s shares outstanding and 3.2% of the fund’s total portfolio.
2. PRIMECAP Management: 63,165,491 shares, representing 0.76% of the company’s shares outstanding and 3.1% of the fund’s total portfolio.
3. Jeff Ubben: 57,750,000 shares, representing 0.69% of the company’s shares outstanding and 20.5% of his total assets managed.
Top 5 Forestry Companies To Invest In 2016: E2open Inc (EOPN)
E2open, Inc., incorporated in September 2003, is a provider of cloud-based, on-demand software solutions. The Company’s software applications allow network participants to input, access and share data and execute business processes across internal operating units and external entities. Its E2open Business Network supports operational business processes of its customers and their trading partners, including supply chain management, procurement, sales and finance functions. The E2open Business Network enables integrated planning and execution across trading partner networks. The Company offers on-demand software solutions, which enable its customers to have constant access to its solutions.
The Company houses the hardware and software in third-party facilities, and provides its customers with access to the software applications, along with data security and storage, backup, and recovery services. It invoices its customers for subscription and support in advanc e for annual use of its software solutions. The Company’s professional services revenue is primarily derived from fees for enabling services, such as solution consulting, solution deployment, B2B on-boarding and solution support that help its customers deploy, manage and support our solutions. These services are sold in conjunction with the sale of its on-demand software solutions or on a standalone basis. It provides professional services both on a fixed fee and a time and materials basis, and invoices its customers in advance, monthly, or upon reaching project milestones.
The Company competes with Infor, Oracle, SAP, GXS Corporation, IBM/Sterling Commerce, SPS Commerce and JDA Software Group, Inc.
- [By Anna Prior]
Cloud-based software provider E2open Inc.’s(EOPN) loss widened in its fiscal first quarter as operating expenses continued to rise.
NGL Energy Partners LP(NGL), which bought oil-storage company TransMontaigne Inc. from Morgan Stanley (MS) (MS) last week, said it is offering to buy the outstanding units of TransMontaigne Partners LP(TLP) (TLP) in a one-for-one exchange of common units.
- [By Evan Niu, CFA]
What: Shares of E2open (NASDAQ: EOPN ) have plunged today by as much as 28% after the company reported fourth-quarter results.
So what: Non-GAAP revenue in the fourth quarter totaled $18.1 million, shy of the $19.7 million in adjusted sales that investors were expecting. The bottom line also registered a miss, with the adjusted loss of $0.06 coming in below the consensus estimate of a $0.05 per share non-GAAP net loss. CEO Mark Woodward’s comments about the company adding a record number of new customers in the quarter didn’t make investors feel any better.
- [By Monica Gerson]
E2open (NASDAQ: EOPN) is projected to post a Q2 loss at $0.15 per share on revenue of $17.23 million.
Bank of the Ozarks (NASDAQ: OZRK) is expected to post its Q3 earnings at $0.60 per share on revenue of $69.57 million.
Top 5 Forestry Companies To Invest In 2016: Ibio Inc (IBIO)
iBio, Inc. (iBio), incorporated on April 17, 2008, is a biotechnology company focused on commercializing its technologies, the iBioLaunch platform for vaccines and therapeutic proteins, as well as the iBioModulator platform for vaccine enhancement. Vaccine candidates on its platform are applicable to newly emerging strains of hemagglutinin type 1 and neuraminidase type 1 (H1N1), swine-like influenza, hemagglutinin type 5 and neuraminidase type 1 (H5N1) avian influenza, yellow fever, and anthrax. The Company licenses or otherwise grants use rights to government and non-governmental organization (NGO) entities for not-for-profit applications of the intellectual property for the development or application for which they granted or were granted funding, and to Fraunhofer USA, Inc. (FhCMB) for research purposes and applications in other fields.
The Company’s platform technology is referred to as iBioLaunch technology or the iBioLaunch platform, and the category o f this technology is referred to as plant-based technology or as a plant-based platform. The Company has exclusive control over, and the rights to ownership of, the intellectual property related to all human health and veterinary influenza applications of the plant-based technology developed by FhCMB. Its property consists of the technology platform pursuant, to which hydroponically grown green plants can be used for the accelerated development and manufacture of high-value proteins of interest as candidate therapeutic products and vaccines applicable to a range of disease agents, such as influenza, sleeping sickness, anthrax, plague, human papillomavirus (HPV), and veterinary influenza applications.
Through FhCMB and their funding from the Bill & Melinda Gates Foundation, it is developing vaccine candidates targeting pathogenic avian influenza (H5N1) viruses based upon the iBioLaunch platform. These candidates have demonstrated immunogenicity and have been succ essfully tested in mice and ferrets for protective efficacy.! Like its candidate vaccines for seasonal influenza, its candidate vaccines for avian influenza are subunit vaccines. iBio has commercial rights to vaccine candidates developed pursuant to its business structure based on fusing a protein component of HPV called the E7 antigen, to the LicKM protein of the bacterium Clostridium thermocellum. It has commercial rights to an oral anthrax booster vaccine candidate developed by FhCMB in collaboration with the Naval Medical Research Center (NMRC).
- [By James E. Brumley]
With just a quick glance, Ibio Inc. (NYSEMKT:IBIO) doesn’t look like anything particularly special. The stock’s just bouncing around, and we’ve not heard any particularly meaningful news from IBIO in a few weeks.
- [By Bryan Murphy]
If the name Ibio Inc. (NYSEMKT:IBIO) rings a bell, it may be because I put some bullish thoughts into print regarding the stock back on June 21st. I reiterated my optimism on July 12th. What can I say? It’s fun to be right. IBIO shares have advanced 17% since my first look in late June. Then again, most of that big jump has unfurled in the last couple of days, meaning Ibio Inc. is overbought. Do we trust the breakout move, or do we fear a pullback? Answer: That depends.
Top 5 Forestry Companies To Invest In 2016: Galectin Therapeutics Inc (GALT)
Galectin Therapeutics Inc., formerly Pro-Pharmaceuticals, Inc., incorporated on January 26, 2001, is a development-stage company. The Company is engaged in drug development to create therapies for cancer and fibrotic disease. As of December 31, 2011, the Company has two compounds in development, one is to be used in cancer therapy and the other intended to be used in the treatment of liver fibrosis and fatty liver disease. These two compounds are produced from different natural starting materials, both possessing the property, which lends itself to binding to and inhibiting galectin proteins. GM-CT-01, the Company’s product candidate for cancer therapy, is a linear polysaccharide polymer consisted of mannose and galactose that has a defined chemical structure and is derived from a plant source. GR-MD-02, the Company’s product for treatment of liver fibrosis and fatty liver disease with inflammation and fibrosis, is a polysaccharide polymer possessing both linear and globul ar structures, which also is derived from a plant source.
GM-CT-01 has in development for the therapy of colorectal cancer and is in a Phase I/II clinical trial as a combination therapy with a tumor vaccine in patients with advanced melanoma. Based on the completed Phase I and partially completed Phase II clinical trials, the Company is exploring two additional potential indicia for the use of GM-CT-01 in combination with cancer chemotherapy. There are two additional pathways for the development of GM-CT-01 for use in treatment of cancer. GM-CT-01 was found to be generally safe when studied in a Phase I clinical trial in end-stage cancer patients with multiple tumor types alone and in combination with 5-Fluorouracil (5-FU), which is an Food and Drug Administration (FDA)-approved chemotherapy used for treatment of various types of cancer.
- [By Roberto Pedone]
Galectin Therapeutics (GALT) offers drug research and development to create new therapies for fibrotic disease and cancer. This stock closed up 9.6% to $12.06 in Monday’s trading session.
Monday’s Volume: 674,000
Three-Month Average Volume: 222,171
Volume % Change: 149%
Shares of GALT jumped higher on Monday after Ascendiant initiated coverage on the stock with a buy recommendation.
From a technical perspective, GALT spiked sharply higher here with strong upside volume. This stock has been uptrending for the last three months, with shares ripping higher from its low of $3.95 to its recent high of $13.21. During that move, shares of GALT have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of GALT within range of triggering a near-term breakout trade. That trade will hit if GALT manages to take out Monday’s high of $12.44 and then once it clears its 52-week high at $13.21 with high volume.
Traders should now look for long-biased trades in GALT as long as it’s trending above some near-term support levels at $11 or at $10 and then once it sustains a move or close above those breakout levels with volume that hits near or above 222,171 shares. If that breakout hits soon, then GALT will set up to enter new 52-week-high territory above $13.21, which is bullish technical price action. Some possible upside targets off that breakout are $15 to $16.
Top 5 Forestry Companies To Invest In 2016: Kadant Inc (KAI)
Kadant Inc., incorporated in November 1991, is a supplier of equipment used in the global papermaking and paper recycling industries and a manufacturer of granules made from papermaking byproducts. Through its Papermaking Systems segment, the Company develops, manufactures and markets a range of equipment and products for the global papermaking, paper recycling, and process industries. Through its Fiber-based Products business, the Company manufacture and sell granules derived from pulp fiber for use as carriers for agricultural, home lawn and garden, and professional lawn, turf and ornamental applications, as well as for oil and grease absorption. Its Papermaking Systems segment consists of product lines, such as stock-preparation, fluid-handling, doctoring and water-management. On May 27, 2011, its subsidiary, Kadant Johnson Europe B.V., acquired all the interests in m-clean papertech holding AB. In April 2013, it completed the acquisition of Companhia Brasileira de Tecn ologia Industrial (CBTI).
The Company’s customer base includes major global paper manufacturers and with its equipment found in most of pulp and paper mills. The Company manufactures its products in nine countries in Europe, North and South America and Asia. It develop, manufacture and market complete custom-engineered systems and equipment, as well as standard individual components, for pulping, de-inking, screening, cleaning, and refining recycled and virgin fibers for preparation for entry into the paper machine. Its principal stock-preparation products include recycling and approach flow systems and Virgin pulping process equipment.
The Company develop, manufacture and market rotary joints, precision unions, steam and condensate systems, components, and controls used primarily in the dryer section of the papermaking process and during the production of corrugated boxboard, metals, plastics, rubber, textiles, chemicals and food. Its principal f luid-handling systems include rotary joints, siphons, turbul! ator bars, and engineered steam and condensate systems. Its mechanical devices, used with rotating shafts, allow the transfer of pressurized fluid from a stationary source into and out of rotating machinery for heating, cooling, or the transfer of fluid power. Its devices, installed primarily inside the rotating cylinders of paper machines, are used to remove condensate from the drying cylinders through rotary joints located on either end of the cylinder. Its steel or stainless steel axial bars, installed on the inside of cylinders, are used to induce turbulence in the condensate layer to improve the uniformity and rate of heat transfer through the cylinders. Its steam systems control the flow of steam from the boiler to the paper drying cylinders, collect condensed steam, and return it to the boiler to improve energy efficiency during the paper drying process.
The Company develop, manufacture and market a range of doctoring systems and related consumables that continuously clean rolls to keep paper machines running efficiently; doctor blades made of a variety of materials to perform functions, including cleaning, creping, web removal, flaking, and the application of coatings, and profiling systems that control moisture, Web curl, and gloss during paper converting. Its principal doctoring products include doctor systems and holders, profiling systems and doctor blades. Its doctor systems clean papermaking rolls to maintain the operation of paper machines and other equipment by placing a blade against the roll at a constant and uniform pressure. A doctor system consists of the structure supporting the blade and the blade holder. It offers profiling systems that control moisture, Web curl, and gloss during paper converting. It manufacture doctor and scraper blades made of a variety of materials, including metal, bi-metal, or synthetic materials that perform a variety of functions, including cleaning, creping, Web removal, flaking and the application of coatings.
The Company devel! ops, manu! facture and markets water-management systems and equipment used to continuously clean paper machine fabrics and rolls, drain water from pulp mixtures, form the sheet or Web, and filter the process water for reuse. Its principal water-management systems include shower and fabric-conditioning systems, formation systems, and water-filtration systems. Its shower and fabric-conditioning systems assist in the removal of contaminants that collect on paper machine fabrics used to convey the paper Web through the forming, pressing and drying sections of the paper machine. A typical paper machine has between 3 and 12 fabrics. It supplies structures that drain, purify, and recycle process water from the pulp mixture during paper sheet and Web formation. It offer a variety of filtration systems and strainers that remove contaminants from process water before reuse and recover reusable fiber for recycling back into the pulp mixture.
The Company competes with Voith Paper GmbH , Metso Corporation, Maschinenfabrik Andritz AG, Deublin Company, Barco Company, Christian Maier GmbH & Co. KG, Duff-Norton Company, Joh. Clouth GmbH & Co. KG, Bonetti, S.p.A., Metso Corporation and IBS-Paper Performance Group.
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market’s best stocks, it’s worth checking up on your companies’ free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That’s what we do with this series. Today, we’re checking in on Kadant (NYSE: KAI ) , whose recent revenue and earnings are plotted below.
Top 5 Forestry Companies To Invest In 2016: William Hill PLC (WMH)
William Hill PLC is a United Kingdom-based gambling company. The Company’s business is to provide its customers with a range of sports betting and gaming opportunities. It is a bookmaker providing fixed odds sports betting. It also offers gaming opportunities. The Company’s segments include Retail distribution channel, which includes activity undertaken in LBOs, including gaming machines; Online segment, which includes activity undertaken online, including an online sportsbook, online casino, online poker sites and other gaming products; Telephone segment, which includes its telephone betting services; US segment, comprises all activity undertaken in the United States; Other activities include on-course betting and greyhound stadia operations. In April 2013, it acquired the remaining 29% stake in William Hill Online from its joint venture partner Playtech Ltd. Effective September 2, 2013, William Hill PLC acquired Miapuesta.es, a provider of gaming and sports betting serv ices. Advisors’ Opinion:
- [By Inyoung Hwang]
Prudential Plc (PRU), which generated 32 percent of its operating income from Asia last year, climbed to its highest price since at least 1988. William Hill (WMH) Plc lost 3.2 percent after JPMorgan Chase & Co. lowered its rating on the bookmaker. Anglo American Plc (AAL) declined 1.4 percent after saying that production at its Kumba (KIO) Iron Ore Ltd. unit fell.
- [By Inyoung Hwang]
Royal Bank of Scotland Group Plc sank 3.3 percent after reporting results and naming the head of its U.K. consumer unit as chief executive officer. William Hill Plc (WMH) dropped the most in four years after the bookmaker posted earnings that missed analysts’ projections. International Consolidated Airlines Group SA (IAG) rose to a five-year high as the parent of British Airways reported an operating profit in the second quarter.